Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Money slowly trickle in...
View:
Post by wildbird1 on Oct 27, 2023 8:02am

Money slowly trickle in...

A few days ago TLT had 216 million shares out.
Today TLT has 223 million shares out(7 million more).

Depending on the value of the warrants being exercised, TLT could have a few hundred thousand $ more in the bank.

Not much but....
Comment by Lesalpes29 on Oct 27, 2023 8:12am
Time to put a bid at .13... seriously. Don't like tghe timing of this financing. GL
Comment by DJDawg on Oct 27, 2023 8:23am
Heard from someone that the deadline to put in paperwork for the LIFE is Oct 30 (end of the day I guess). All we can do is hope that the new buyers are interested enough to hold on to the shares and the price drifts up a bit.
Comment by riverrrow on Oct 27, 2023 9:23am
From the news release: "The Offering is scheduled to close on or about the week of October 30, 2023 and is subject to the receipt of all necessary approvals, including the approval of the TSXV".  Week of October 30, not day of.  Also, on or about.  
Comment by wildbird1 on Oct 27, 2023 9:29am
Big correction... I hope somebody can prove me wrong, but the lowest warrant are at .35$ each. But in the Nov,21,2022 pressrelease 7.8 million options were granted at .25$ each. If the 7 million more shares out are these options being exercised, then TLT has close to $1.9 million more in the bank.
Comment by riverrrow on Oct 27, 2023 9:49am
The problem with options is that ordinary shareholders often get quite irate when the options are exercised and the shares are subsequently sold. 
Comment by ggrellette on Oct 27, 2023 10:24am
Sadly options are utilized that way because it is seen by the industry as free money. When filing out your proxy stop agreeing to stock options is the only way it will stop. Now mgt. will cry foul if they can not grant options. the options are for incentive purposes but it works both ways.
Comment by 2b7f6fab on Oct 27, 2023 10:33am
Maybe you're looking at Theralase website for the share count.  I always go to the TMX website for such information because it is always up to date there.  Share issuances have to be reported/approved by TMX the regulatory body so it is always up to date.  Not so with Theralase website. I imagine with the skinny crew some things get overlooked.  The two previous PPs, one ...more  
Comment by 2b7f6fab on Oct 27, 2023 11:03am
Slight correction to my previous post.  TMX is not a regulatory body but it is Theralase transfer agent via TSX Trust so yes any stock issuances has to be reported to it. Another thought and correct me if I'm wrong.  The wording of the LIFE offering with RCC seems to indicate that RCC has committed to the minimum share offering.  So even if there aren't enough client takers ...more  
Comment by 99942Apophis on Oct 27, 2023 5:10pm
You wage a good argument 2b7f6fab, to theorize RCC has committed to the minimum funds would in my wild guess be that they have within their ranks a person competent enough in medical knowledge to desire a sizable position themselves. It could also be that some of their clients have expressed interest in what RCC would consider a rising star. Financial institutions do take long shots but knowledge ...more  
Comment by BlueFranky on Oct 27, 2023 6:44pm
Apophis, please check your inbox
Comment by 2b7f6fab on Oct 27, 2023 9:50pm
99942A, RCC doesn't need to have anyone on staff to evaluate the medical technology.  Just pay a couple Urologists to spend some time assessing.  Remember there was a short video a while back with one of our PIs and that renown Urologic Oncologist from MD Amderson talking about how great this technology is progressing?  Just what the Dr ordered. I took a look at RCC website ...more  
Comment by 2b7f6fab on Oct 28, 2023 5:30am
No love here on this board.  98 views and not one like.  Might as well pour myself a tall vodka and talk into the corner of my living room. Ever try to keep a balloon under water? day by  day this balloon is getting bigger.
Comment by Benedictus on Oct 28, 2023 12:10am
You raise a fair point about the possibility of a few options being exercised during Q3 but still it seems doubtful to me and we'll have to wait for Q3 financials to drop before confirming. Of more consequence going into Q3 24 will be the 10.2M .26c options set to expire. By then this company will hopefully be on much firmer financial footing and options being exercised will be viewed more as ...more  
Comment by Benedictus on Oct 27, 2023 11:55pm
Wildbird,  sedar financials show the share count went from 216.5M at end of Q1 to 221.3M at end of Q2 due to the 4.8M share issuance on 6/30. With the Sept 8th issuance of 1.8M shares, the current share count stands at 223.1M , which will increase soon based on forthcoming details of the closing. Also, it's worth noting 3.1M warrants expired a few weeks ago and another 4.1M warrants will ...more  
Comment by wildbird1 on Oct 29, 2023 7:25am
Thank's Benedictus for the clarification, I appreciate when somebody take the time to read my posts and correct my mistakes. At least now I know were these extra shares came from.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250